Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | glucagon-like peptide 1 receptor | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Loa Loa (eye worm) | pigment dispersing factor receptor c | glucagon-like peptide 1 receptor | 463 aa | 388 aa | 25.8 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Loa Loa (eye worm) | doublecortin family protein | 0.0418 | 0.1243 | 1 |
Schistosoma mansoni | lipoxygenase | 0.1595 | 0.6584 | 0.6099 |
Brugia malayi | Doublecortin family protein | 0.0418 | 0.1243 | 1 |
Toxoplasma gondii | perforin-like protein PLP1 | 0.0192 | 0.0217 | 0.5 |
Echinococcus multilocularis | macrophage expressed protein | 0.1737 | 0.723 | 0.6836 |
Brugia malayi | hypothetical protein | 0.0418 | 0.1243 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0418 | 0.1243 | 1 |
Brugia malayi | hypothetical protein | 0.0418 | 0.1243 | 1 |
Echinococcus granulosus | macrophage expressed protein | 0.1737 | 0.723 | 0.6836 |
Schistosoma mansoni | lipoxygenase | 0.2348 | 1 | 1 |
Onchocerca volvulus | 0.0418 | 0.1243 | 0.5 | |
Chlamydia trachomatis | hypothetical protein | 0.0192 | 0.0217 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0418 | 0.1243 | 1 |
Toxoplasma gondii | MAC/Perforin domain-containing protein | 0.0192 | 0.0217 | 0.5 |
Echinococcus multilocularis | arachidonate 5 lipoxygenase | 0.2348 | 1 | 1 |
Onchocerca volvulus | 0.0418 | 0.1243 | 0.5 | |
Plasmodium falciparum | LCCL domain-containing protein | 0.0418 | 0.1243 | 1 |
Plasmodium vivax | multidomain scavenger receptor, putative | 0.0418 | 0.1243 | 1 |
Schistosoma mansoni | hypothetical protein | 0.1737 | 0.723 | 0.6836 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | 8.9125 uM | PubChem BioAssay. qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode). (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 31.6228 uM | PubChem BioAssay. qHTS for Inhibitors of ATXN expression. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 39.8107 uM | PubChem BioAssay. qHTS for Agonist of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 56.2341 uM | PubChem BioAssay. qHTS for Antagonist of cAMP-regulated guanine nucleotide exchange factor 3 (EPAC1): primary screen. (Class of assay: confirmatory) | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.